Phaarmasia Profile
Key Indicators
- Authorised Capital ₹ 10.00 Cr
as on 02-07-2024
- Paid Up Capital ₹ 6.83 Cr
as on 02-07-2024
- Company Age 43 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.45 Cr
as on 02-07-2024
- Satisfied Charges ₹ 20.76 Cr
as on 02-07-2024
- Revenue 58.35%
(FY 2023)
- Profit 18.61%
(FY 2023)
- Ebitda 11.03%
(FY 2023)
- Net Worth -10.36%
(FY 2023)
- Total Assets 34.02%
(FY 2023)
About Phaarmasia
It is listed on the Bombay Stock Exchange(BSE) under the ticker symbol 523620.
The Company is engaged in the Fmcg Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 10.00 Cr and a paid-up capital of Rs 6.83 Cr.
The company currently has active open charges totaling ₹1.45 Cr. The company has closed loans amounting to ₹20.76 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Phaarmasia Limited India are Urvashi Bhatia as COMPANY SECRETARY and Eswara Nagineni as Cfo. Pravin Hegde, Rashmi Sapte, Vinay Sapte, and Three other members serve as directors at the Company.
- CIN/LLPIN
L24239TG1981PLC002915
- Company No.
002915
- Stock Symbol
BSE : 523620
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
06 Feb 1981
- Date of AGM
10 Jul 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Listed
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Phaarmasia Limited offer?
Phaarmasia Limited offers a wide range of products and services, including Cardiovascular Drugs & Medication, Diabetes Medicine, Sexual Wellness Products, Fertility Enhancer, Brain & Nervous System Drugs, Antimigraine Drug, Anti Infective Drugs & Medicines, HIV Drugs, TB, Tumor & Cancer Drugs, Anti Cancer Injection.
Who are the key members and board of directors at Phaarmasia?
Executive Team (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Urvashi Bhatia  | Company Secretary | 03-Jan-2020 | Current |
| Eswara Nagineni | CFO | 12-Feb-2016 | Current |
Board Members(6)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Pravin Hegde | Director | 14-Feb-2017 | Current |
| Rashmi Sapte | Director | 14-Feb-2015 | Current |
| Vinay Sapte | Director | 30-Apr-2009 | Current |
| Maneesh Sapte | Director | 01-Mar-2006 | Current |
| Naga Yallapragada | Whole-Time Director | 10-Sep-2004 | Current |
| Ajit Jamkhandikar | Director | 14-Aug-2018 | Current |
Financial Performance and Corporate Structure Insights of Phaarmasia.
Phaarmasia Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 58.35% increase. The company also saw a substantial improvement in profitability, with a 18.61% increase in profit. The company's net worth observed a substantial decline by a decrease of 10.36%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Phaarmasia?
In 2023, Phaarmasia had a promoter holding of 73.51% and a public holding of 26.48%. The company had 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maneesh Pharmaceuticals LimitedActive 39 years 4 monthsPravin Hegde, Rashmi Sapte and 3 more are mutual person
- Svizera Labs Private LimitedActive 27 years 8 months
Rashmi Sapte, Vinay Sapte and 1 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
India Equipment Leasind Ltd. Creation Date: 31 Dec 1994 | ₹3.74 M | Open |
Nagarjuna Investment Trust Ltd. Creation Date: 29 Jun 1993 | ₹0.79 M | Open |
Nagarjuna Investment Trust Ltd Creation Date: 10 Jun 1993 | ₹0.34 M | Open |
How Many Employees Work at Phaarmasia?
Phaarmasia has a workforce of 14 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Phaarmasia, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Phaarmasia's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
